131 related articles for article (PubMed ID: 11943941)
1. The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway-based assays.
Moore GW; Smith MP; Patel Y; Savidge GF
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):261-9. PubMed ID: 11943941
[TBL] [Abstract][Full Text] [Related]
2. Further evidence of false negative screening for lupus anticoagulants.
Moore GW; Henley A; Greenwood CK; Rangarajan S
Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
[TBL] [Abstract][Full Text] [Related]
3. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
[No Abstract] [Full Text] [Related]
4. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time.
Moore GW; Savidge GF; Smith MP
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):767-74. PubMed ID: 11132656
[TBL] [Abstract][Full Text] [Related]
5. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
7. Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulant.
Ames PR; Iannaccone L; De Iasio R; Brancaccio V
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):563-7. PubMed ID: 11685045
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions.
Martin BA; Branch DW; Rodgers GM
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):31-8. PubMed ID: 8845460
[TBL] [Abstract][Full Text] [Related]
9. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
10. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
Triplett DA
Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
[TBL] [Abstract][Full Text] [Related]
11. Use of a modified activated partial thromboplastin time to detect lupus anticoagulants.
Cloherty T; Golden EA; Lind SE
Thromb Res; 1996 Jul; 83(2):137-42. PubMed ID: 8837312
[TBL] [Abstract][Full Text] [Related]
12. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of clotting times in the laboratory detection of lupus anticoagulants.
Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
Thromb Res; 2001 Nov; 104(4):275-82. PubMed ID: 11728529
[TBL] [Abstract][Full Text] [Related]
14. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH.
Brandt JT; Barna LK; Triplett DA
Thromb Haemost; 1995 Dec; 74(6):1597-603. PubMed ID: 8772243
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
16. The use of frozen-thawed platelet-derived phospholipids as a confirmatory test for the diagnosis of lupus anticoagulants. Comparison with two commercial confirmatory system tests.
Cappucci G; Grandone E; Giuliani N; Margaglione M; Di Minno G
Thromb Res; 1999 Jun; 94(6):373-80. PubMed ID: 10390132
[TBL] [Abstract][Full Text] [Related]
17. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
Moore GW; Smith MP; Savidge GF
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
[TBL] [Abstract][Full Text] [Related]
18. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
Moore GW; Tugnait S; Savidge GF
Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
[TBL] [Abstract][Full Text] [Related]
19. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
Genzen JR; Miller JL
Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
[TBL] [Abstract][Full Text] [Related]
20. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
Triplett DA; Barna LK; Unger GA
Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
